Co-diagnostics Share Price Today
(NASDAQ: CODX)

Name: Co-diagnostics Share Price Today (NASDAQ: CODX) - Co-diagnostics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Co-diagnostics share price is $0.49 & ₹42.61 as on 6 Mar 2025, 2.30 'hrs' IST

$0.49

▲

0.01

(1.05%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Co-diagnostics share price in Dollar and Rupees. Guide to invest in Co-diagnostics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Co-diagnostics, along with analyst recommendations, forecasts, and comprehensive financials.

Co-diagnostics share price movements

Today's Low: $0.48
Today's High: $0.52
$0.49
1.96%
Downside
Day's Volatility :7.58%
Upside
5.73%
52 Weeks Low: $0.46
52 Weeks High: $2.23
$0.49
7.12%
Downside
52 Weeks Volatility :79.59%
Upside
78.03%

Co-diagnostics (CODX) Returns

Period	Co-diagnostics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-39.94%	3.7%	0.0%
6 Months	-63.11%	-2.8%	0.0%
1 Year	-57.17%	2.5%	0.0%
3 Years	-90.86%	12.9%	-11.6%

Co-diagnostics (CODX) Key Statistics

in dollars & INR

Previous Close	$0.4874
Open	$0.4901
Today's High	$0.5198
Today's Low	$0.4804
Market Capitalization	$15.6M
Today's Volume	$48.5K
52 Week High	$2.2299
52 Week Low	$0.4551
Revenue TTM	$7.3M
EBITDA	$-38.7M
Earnings Per Share (EPS)	$-1.4
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.31%
Return On Equity TTM	-50.57%

How to invest in Co-diagnostics Stock (CODX) from India?

It is very easy for Indian residents to invest directly in Co-diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Co-diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Co-diagnostics or CODX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Co-diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Co-diagnostics shares which would translate to 1.775 fractional shares of Co-diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Co-diagnostics, in just a few clicks!

Returns in Co-diagnostics (CODX) for Indian investors in Rupees

The Co-diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Co-diagnostics investment value today

Current value as on today

₹47,558

Returns

₹52,442

(-52.44%)

Returns from Co-diagnostics Stock

₹57,391 (-57.39%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Co-diagnostics (CODX)

-42%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Co-diagnostics Stock from India on INDmoney has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Co-diagnostics

Vanguard Group Inc
5.57%
Private Asset Group LLC
3.70%
Renaissance Technologies Corp
1.74%
BlackRock Inc
1.58%
Geode Capital Management, LLC
1.08%
Bridgeway Capital Management, LLC
0.85%

Analyst Recommendation on Co-diagnostics

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Co-diagnostics(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Co-diagnostics Stock (CODX)

What analysts predicted

Upside of 206.12%

Target:

$1.50

Current:

$0.49

Insights on Co-diagnostics Stock (Ticker Symbol: CODX)

Price Movement
In the last 1 month, CODX stock has moved down by -27.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 161.10K → 641.14K (in $), with an average increase of 74.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.59M → -9.69M (in $), with an average decrease of 27.6% per quarter
CODX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 112.5%
CODX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 229.3%
Price to Sales
ForCODX every $1 of sales, investors are willing to pay $2.0, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

CODX Co-diagnostics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$39.9K	↑ 420.9%
Net Income	$-6.3M	↓ 9.88%
Net Profit Margin	-15.7K%	↑ 75113.61%

	FY19	Y/Y Change
Revenue	$215.0K	↑ 438.63%
Net Income	$-6.1M	↓ 3.23%
Net Profit Margin	-2.8K%	↑ 12891.09%

	FY20	Y/Y Change
Revenue	$74.6M	↑ 34579.9%
Net Income	$42.5M	↓ 799.91%
Net Profit Margin	56.98%	↑ 2880.16%

	FY21	Y/Y Change
Revenue	$97.9M	↑ 31.3%
Net Income	$36.7M	↓ 13.7%
Net Profit Margin	37.45%	↓ 19.53%

	FY22	Y/Y Change
Revenue	$34.2M	↓ 65.04%
Net Income	$-14.2M	↓ 138.84%
Net Profit Margin	-41.61%	↓ 79.06%

	FY23	Y/Y Change
Revenue	$6.8M	↓ 80.09%
Net Income	$-35.3M	↑ 148.15%
Net Profit Margin	-518.68%	↓ 477.07%

	Q2 FY23	Q/Q Change
Revenue	$197.8K	↓ 67.14%
Net Income	$-8.9M	↑ 54.96%
Net Profit Margin	-4.5K%	↓ 3552.76%

	Q3 FY23	Q/Q Change
Revenue	$2.5M	↑ 1142.18%
Net Income	$-6.0M	↓ 32.93%
Net Profit Margin	-243.47%	↑ 4265.4%

	Q4 FY23	Q/Q Change
Revenue	$3.6M	↑ 44.69%
Net Income	$-14.7M	↑ 145.34%
Net Profit Margin	-412.82%	↓ 169.35%

	Q1 FY24	Q/Q Change
Revenue	$252.7K	↓ 92.89%
Net Income	$-9.3M	↓ 36.55%
Net Profit Margin	-3.7K%	↓ 3271.54%

	Q2 FY24	Q/Q Change
Revenue	$161.1K	↓ 36.26%
Net Income	$-7.6M	↓ 18.39%
Net Profit Margin	-4.7K%	↓ 1032.72%

	Q3 FY24	Q/Q Change
Revenue	$641.1K	↑ 297.97%
Net Income	$-9.7M	↑ 27.6%
Net Profit Margin	-1.5K%	↑ 3204.71%

	FY18	Y/Y Change
Profit	$30.5K	↑ 314.67%

	FY19	Y/Y Change
Profit	$102.5K	↑ 235.99%

	FY20	Y/Y Change
Profit	$58.0M	↑ 56424.01%

	FY21	Y/Y Change
Profit	$86.3M	↑ 48.91%

	FY22	Y/Y Change
Profit	$28.7M	↓ 66.71%

	FY23	Y/Y Change
Profit	$2.6M	↓ 90.86%

	Q2 FY23	Q/Q Change
Profit	$-261.3K	↓ 362.03%

	Q3 FY23	Q/Q Change
Profit	$2.2M	↓ 942.49%

	Q4 FY23	Q/Q Change
Profit	$274.5K	↓ 87.53%

	Q1 FY24	Q/Q Change
Profit	$-312.3K	↓ 213.8%

	Q2 FY24	Q/Q Change
Profit	$-389.4K	↑ 24.67%

	Q3 FY24	Q/Q Change
Profit	$343.7K	↓ 188.28%

	FY18	Y/Y Change
Operating Cash Flow	$-4.1M	↑ 27.05%
Investing Cash Flow	$-380.3K	↑ 100.91%
Financing Cash Flow	$1.9M	↓ 68.4%

	FY19	Y/Y Change
Operating Cash Flow	$-5.5M	↑ 35.42%
Investing Cash Flow	$-435.2K	↑ 14.44%
Financing Cash Flow	$5.9M	↑ 214.65%

	FY20	Y/Y Change
Operating Cash Flow	$28.2M	↓ 609.77%
Investing Cash Flow	$-5.8M	↑ 1238.17%
Financing Cash Flow	$19.7M	↑ 234.44%

	FY21	Y/Y Change
Operating Cash Flow	$41.1M	↑ 45.86%
Investing Cash Flow	$4.1M	↓ 170.37%
Financing Cash Flow	$450.4K	↓ 97.72%

	FY22	Y/Y Change
Operating Cash Flow	$6.6M	↓ 84.01%
Investing Cash Flow	$-58.2M	↓ 1519.19%
Financing Cash Flow	$-14.0M	↓ 3215.91%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.2M	↓ 5.27%
Investing Cash Flow	$13.2M	↓ 224.49%
Financing Cash Flow	$-555.7K	↑ 15.25%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-6.6M	↑ 26.59%
Investing Cash Flow	$3.2M	↓ 76.05%
Financing Cash Flow	$-166.3K	↓ 70.07%

Co-diagnostics Technicals Summary

Sell

Neutral

Buy

Co-diagnostics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Co-diagnostics (CODX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Co-diagnostics Inc	-31.79%	-63.11%	-57.17%	-90.86%	-94.99%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Co-diagnostics Inc	4.96	NA	0.0	0.0	-0.51	-0.28	NA	2.0
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Co-diagnostics Inc	Sell	$15.6M	-94.99%	4.96	0.0%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Co-diagnostics

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Organization	Co-diagnostics
Employees	155
CEO	Mr. Dwight H. Egan
Industry	Health Technology

Management People of Co-diagnostics

Name	Title
Mr. Dwight H. Egan	Chairman & CEO
Mr. Brian L. Brown CPA	CFO & Company Secretary
Mr. Richard David Abbott	President
Mr. David Nielsen	Chief Operating Officer
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. Christopher Thurston	Chief Technology Officer
Mr. Andrew Benson	Head of Investor Relations
Dr. Mayuranki Almaula	Senior Vice President of Overseas Operations & Strategic Alliances
Mr. Cameron Gundry	Head of Commercialization LATAM/EUR
Mr. Seth Egan	Chief Commercialization Officer

Important FAQs about investing in CODX Stock from India :

What is Co-diagnostics share price today?

Co-diagnostics share price today stands at $0.49, Open: $0.49 ; Previous Close: $0.49 ; High: $0.52 ; Low: $0.48 ; 52 Week High: $2.23 ; 52 Week Low: $0.46.

The stock opens at $0.49, after a previous close of $0.49. The stock reached a daily high of $0.52 and a low of $0.48, with a 52-week high of $2.23 and a 52-week low of $0.46.

Can Indians buy Co-diagnostics shares?

Yes, Indians can invest in the Co-diagnostics (CODX) from India.

With INDmoney, you can buy Co-diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Co-diagnostics at zero transaction cost.

How can I buy Co-diagnostics shares from India?

It is very easy to buy Co-diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Co-diagnostics (CODX) be purchased?

Yes, you can buy fractional shares of Co-diagnostics with INDmoney app.

What are the documents required to start investing in Co-diagnostics stocks?

To start investing in Co-diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.